BioSpace News Archive

Galderma announced positive data from three pivotal phase III trials in atopic dermatitis and prurigo nodularis – ARCADIA 1 and 2 and OLYMPIA 1, respectively.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announces that it will host a virtual KOL event on Bria-IMT™ potential in advanced metastatic breast cancer on Thursday, October 26, 2023 at 10:00am ET.

Immunis, Inc. is delighted to announce that its Chief Business Officer, Mark Cabato, will be a keynote speaker at this year’s Drug Discovery Strategic Summit. Mark is set to delve deeper into Immunis’ cutting-edge cellular secretome technology, which has shown pre-clinical efficacy in improving muscle regeneration and functio

Xenetic Biosciences, Inc. today announced that Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences, will participate at the Virtual Investor Ask the CEO Conference on October 24, 2023 at 1:00 PM ET.

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, announced that its proof-of-concept robotic system, developed along with UCSF, Cytiva, Thermo Fisher Scientific and Charles River, has been successfully completed.

Renovaro Biosciences Inc., a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram Miller will join its Board of Directors.

OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems

PathogenDx (PathogenDx or Company), a leader in next-generation microarray technology for better health and safety, announced the launch of its new and improved rapid semi-quantification assay

MCRA, LLC is pleased to announce its role in assisting Attune Medical with its De Novo marketing authorization from the US Food and Drug Administration (FDA) for the ensoETM™ device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.

Nihon Kohden, a global leader in medical electronic equipment, is proud to introduce the One View solution as a groundbreaking feature in the Neuromaster G1 intraoperative neuromonitoring (IONM) system.